Skip to main content
Log in

Enzalutamide recommended for prostate cancer by NICE

  • Media release
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • NICE. NICE publishes draft guidance on two prostate cancer treatments. Media Release : 11 Dec 2015. Available from: URL: http://www.nice.org.uk

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Enzalutamide recommended for prostate cancer by NICE. PharmacoEcon Outcomes News 743, 34 (2015). https://doi.org/10.1007/s40274-015-2699-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-015-2699-0

Navigation